All News

    Self-Advocacy Can Help Patients Navigate Cancer Treatment Challenges

    June 19th 2025, 9:00pm

    Article

    Speaking up during cancer treatment helped one patient manage side effects, address insurance issues and stay productive throughout chemotherapy.

    Experts Walk Through Recent Hematologic Malignancy Treatment Updates

    June 19th 2025, 8:00pm

    Video

    Dr. Raajit K. Rampal and Dr. Joshua K. Sabari walk through updates for patients in the treatment of blood cancers, including polycythemia vera.

    Breaking Down the Impact of SERENA-6 for Some With Breast Cancer

    June 19th 2025, 7:00pm

    Article

    Dr. Joshua K. Sabari and Dr. Julia E. McGuinness discussed the SERENA-6 trial and its outcomes for patients with ESR1-mutated HR+/HER2— breast cancer.

    Why I Don’t Call Myself a Survivor With Metastatic Breast Cancer

    June 19th 2025, 5:00pm

    Article

    Living with metastatic breast cancer, I find it hard to relate to the term “survivor.”

    Why is Clinical Trial Enrollment Important for Those With Kidney Cancer?

    June 19th 2025, 4:00pm

    Article

    Dr. Michael Serzan explains the importance of clinical trial enrollment for patients with kidney cancer and highlighted findings from the STELLA-002 trial.

    FDA Updates Talzenna-Xtandi Label for HRR-Mutated Metastatic Prostate Cancer

    June 19th 2025, 3:00pm

    Article

    FDA approves updated labeling for Talzenna plus Xtandi in men with HRR gene-mutated metastatic prostate cancer, showing a 14-month survival benefit.

    Exploring Palliative and Curative Radiation for Lung Cancer

    June 19th 2025, 1:00pm

    Article

    Dr. Jared Weiss explained that radiation for lung cancer may ease symptoms or aim to cure, with newer targeted forms potentially boosting immune responses.

    When a “Thinking of You” Card Isn’t the Right Support for a Patient

    June 18th 2025, 9:00pm

    Article

    Those of us who’ve survived our cancer treatment journeys need to be role models to those who follow us.

    FDA Approves Monjuvi With Revlimid and Rituxan for Follicular Lymphoma

    June 18th 2025, 8:00pm

    Article

    The FDA approved Monjuvi with Revlimid and Rituxan for R/R follicular lymphoma after it showed significantly longer progression-free survival vs placebo.

    Recent SCLC Data May Impact How Patients Are Treated Day-to-Day

    June 18th 2025, 7:12pm

    Article

    Various trials within the small cell lung cancer space were brought to light following recent data, impacting how patients will be treated in the future.